Drug-induced thrombocytopenia (DITP) can be triggered by antibiotics; however, the details remain unclear. Here, we evaluated the expression profiles of DITP using the Japanese Adverse Drug Event Report (JADER) database. We analyzed reports of DITP between April 2004 and January 2021 from the JADER database. The reporting odds ratio (ROR) and 95% confidence interval (CI) were used to detect DITP signals. Factors thought to affect DITP, such as male sex and an age of at least 60 years, were added as covariates. We evaluated the time-to-onset profile and hazard type using the Weibull shape parameter. The JADER database contained 1,048,576 reports. Twelve of 60 antibiotics showed signals for DITP; the RORs (95% CIs) for ampicillin/sulbactam, ceftazidime, cefozopran, ciprofloxacin, fluconazole, fos-fluconazole, linezolid, pazufloxacin, piperacillin/tazobactam, teicoplanin, trimethoprim/sulfamethoxazole, and voriconazole were 1.75 (1.41-2.16), 1.77 (1.42-2.18), 1.35 (1.06-1.72), 2.56 (2.19-2.98), 1.93 (1.67-2.23), 2.08 (1.76-2.46), 5.29 (2.73-9.60), 1.92 (1.51-2.41), 1.54 (1.05-2.19), 1.47 (1.16-1.84), 1.92 (1.73-2.14), and 2.32 (1.59-3.30), respectively. In multiple logistic regression analysis, 7 and 6 antibiotics were detected for the factors age and male sex, respectively. The median times-to-onset of DITP for ciprofloxacin (oral treatment), fluconazole, linezolid, piperacillin/tazobactam, and trimethoprim/sulfamethoxazole were 91, 91, 11.5, 10, and 9 days, respectively. Furthermore, the 95% CI of the Weibull shape parameter β for these antibiotics was above and excluded 1, indicating that the antibiotics were the wear out failure type. We revealed the expression profiles of DITP following treatment with 12 antibiotics.

1. Zarychanski, R, Houston, DS. Assessing thrombocytopenia in the intensive care unit: the past, present, and future. Hematology. 2017;2017(1):660-666.
Google Scholar | Crossref | Medline2. van den Bemt, PM, Meyboom, RH, Egberts, AC. Drug-induced immune thrombocytopenia. Drug Saf. 2013;27(15):1243-1252.
Google Scholar | Crossref3. Murphy, MF, Riordan, T, Minchinton, RM, et al. Demonstration of an immune-mediated mechanism of penicillin-induced neutropenia and thrombocytopenia. Br J Haematol. 1983;55(1):155-160.
Google Scholar | Crossref | Medline4. Bougie, D, Aster, R. Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen. Blood. 2001;97(12):3846-3850.
Google Scholar | Crossref | Medline5. Bernstein, WB, Trotta, RF, Rector, JT, Tjaden, JA, Barile, AJ. Mechanisms for linezolid-induced anemia and thrombocytopenia. Ann Pharmacother. 2003;37(4):517-520.
Google Scholar | SAGE Journals | ISI6. Veldman, G, van der Pijl, JW, Claas, FHJ. Teicoplanin-induced thrombocytopenia. Nephron. 1996;73(4):721-722.
Google Scholar | Crossref | Medline7. Shah, RA, Musthaq, A, Khardori, N. Vancomycin-induced thrombocytopenia in a 60-year-old man: a case report. J Med Case Rep. 2009;3:7290.
Google Scholar | Crossref | Medline8. Walker, AS, Causey, MW, Sebesta, JA. Cefazolin-induced neutropenia and thrombocytopenia following trauma: a case report. Mil Med. 2012;177(3):352-354.
Google Scholar | Crossref | Medline9. Gaudel, P, Qavi, AH, Basak, P. Life-threatening thrombocytopenia secondary to trimethoprim/sulfamethoxazole. Cureus. 2017;9(12):e1963.
Google Scholar | Medline10. Noguchi, Y, Ueno, A, Otsubo, M, et al. A simple method for exploring adverse drug events in patients with different primary diseases using spontaneous reporting system. BMC Bioinf. 2018;19(1):124.
Google Scholar | Crossref | Medline11. Nakao, S, Hatahira, H, Sasaoka, S, et al. Evaluation of drug-induced photosensitivity using the Japanese adverse drug event report (JADER) Database. Biol Pharm Bull. 2017;40(12):2158-2165.
Google Scholar | Crossref | Medline12. Kose, E, Uno, K, Hayashi, H. Evaluation of the expression profile of extrapyramidal symptoms due to antipsychotics by data mining of Japanese adverse drug event report (JADER) database. Yakugaku Zasshi. 2017;137(1):111-120.
Google Scholar | Crossref | Medline13. Hashiguchi, M, Imai, S, Uehara, K, Maruyama, J, Shimizu, M, Mochizuki, M. Factors affecting the timing of signal detection of adverse drug reactions. PLoS One. 2015;10(12):e0144263.
Google Scholar | Crossref | Medline14. van Puijenbroek, ENP, Bate, A, Leufkens, HGM, Lindquist, M, Orre, R, Egberts, ACG. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(1):3-10.
Google Scholar | Crossref | Medline | ISI15. Tsuji, Y, Holford, NHG, Kasai, H, et al. Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients. Br J Clin Pharmacol. 2017;83(8):1758-1772.
Google Scholar | Crossref | Medline16. Sauzet, O, Carvajal, A, Escudero, A, Molokhia, M, Cornelius, VR. Illustration of the weibull shape parameter signal detection tool using electronic healthcare record data. Drug Saf. 2013;36(10):995-1006.
Google Scholar | Crossref | Medline | ISI17. Kotani, A, Hirai, J, Hamada, Y, Fujita, J, Hakamata, H. Determination of ceftriaxone concentration in human cerebrospinal fluid by high-performance liquid chromatography with UV detection. J Chromatogr B. 2019;1124:161-164.
Google Scholar | Crossref | Medline18. Chen, XK, Shi, HY, Leroux, S, et al. Penetration of cefotaxime into cerebrospinal fluid in neonates and young infants. Antimicrob Agents Chemother. 2018;62(4):e02448-e02517.
Google Scholar | Crossref | Medline19. Wilson, AP . Clinical pharmacokinetics of teicoplanin. Clin Pharmacokinet. 2000;39(3):167-183.
Google Scholar | Crossref | Medline20. Zhou, Z-Y, Zhao, X-Q, Shan, B-Z, et al. Efficacy and safety of linezolid in treating gram-positive bacterial infection in the elderly: a retrospective study. Indian J Microbiol. 2014;54(1):104-107.
Google Scholar | Crossref | Medline21. Kaya Kılıç, E, Bulut, C, Sönmezer, MÇ, et al. Risk factors for linezolid-associated thrombocytopenia and negative effect of carbapenem combination. J Infect Dev Ctries 2019; 13 (10): 886-891.
Google Scholar | Crossref | Medline22. Tanihara, S, Suzuki, S. Estimation of the incidence of MRSA patients: evaluation of a surveillance system using health insurance claim data. Epidemiol Infect. 2016;144(11):2260-2267.
Google Scholar | Crossref | Medline23. Kawasuji, H, Tsuji, Y, Ogami, C, et al. Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients. BMC Pharmacol Toxicol. 2021;22(1):13.
Google Scholar | Crossref | Medline24. Restrepo, MI, Babu, BL, Reyes, LF, et al. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J. 2018;52(2):1701190.
Google Scholar | Crossref | Medline25. Niwa, T, Imagawa, Y, Yamazaki, H. Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450. Curr Drug Metabol. 2014;15(7):651-679.
Google Scholar | Crossref | Medline26. Waters, NJ . Evaluation of drug-drug interactions for oncology therapies:in vitro-in vivoextrapolation model-based risk assessment. Br J Clin Pharmacol. 2015;79(6):946-958.
Google Scholar | Crossref | Medline27. Subhani, S, Jamil, K. Molecular docking of chemotherapeutic agents to CYP3A4 in non-small cell lung cancer. Biomed Pharmacother. 2015;73:65-74.
Google Scholar | Crossref | Medline28. Wang, Z, Cai, XJ, Chen, LY, et al. Factors potentially associated with gemcitabine-based chemotherapy-induced thrombocytopenia in Chinese patients with nonsmall cell lung cancer. J Canc Res Therapeut. 2018;14:S656-S660.
Google Scholar | Crossref | Medline29. Vayne, C, Guéry, E-A, Rollin, J, Baglo, T, Petermann, R, Gruel, Y. Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia. J Clin Med. 2020;9(7):2212.
Google Scholar | Crossref